Safety and Efficacy of Bimagrumab and Semaglutide in Adults Who Are Overweight or Obese

NCT05616013 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

507

Enrollment

INDUSTRY

Sponsor class

Conditions

Obesity
Obese
Overweight or Obesity

Interventions

BIOLOGICAL: Bimagrumab
DRUG: Semaglutide
OTHER: Placebo

Sponsor

Eli Lilly and Company

Collaborators

[object Object]